Acquisition of Navigenics Expands Life Technologies' Capabilities in Diagnostics
Life Technologies Corporation (NASDAQ: LIFE) announced Monday the acquisition of Navigenics. This acquisition represents Life Technologies' first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.